Sensory neuron BRAF mediates opioid-induced hyperalgesia and tolerance via presynaptic NMDA receptor hyperactivity

Insights

Opioid-induced pain hypersensitivity and tolerance involve NMDA receptor (NMDAR) hyperactivity. BRAF kinase translocation to spinal cord synaptosomes drives this NMDAR overactivity, impacting pain management.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Molecular Biology

Background:

  • Opioids are vital for severe pain but cause hyperalgesia and tolerance.
  • NMDA receptor (NMDAR) hyperactivity in the spinal cord contributes to these opioid-induced effects.
  • The precise signaling pathways driving NMDAR hyperactivity remain poorly understood.

Purpose of the Study:

  • To elucidate the molecular mechanisms linking opioid administration to NMDAR hyperactivity.
  • To investigate the role of BRAF kinase in mediating opioid-induced hyperalgesia and tolerance.
  • To explore the therapeutic potential of targeting BRAF for improved opioid analgesia.

Main Methods:

  • Morphine administration in rats to induce hyperalgesia and tolerance.
  • Assessment of BRAF translocation, MEK-ERK phosphorylation, and NMDAR activity in spinal cord synaptosomes.
  • Pharmacological inhibition of BRAF (vemurafenib) and MEK.
  • Conditional knockout of Braf in dorsal root ganglion (DRG) neurons.
  • Electrophysiological recordings of NMDAR hyperactivity in spinal dorsal horn neurons.
  • Evaluation of analgesic effects, hyperalgesia, and tolerance in response to BRAF inhibition or Braf deletion.

Main Results:

  • Morphine promoted BRAF translocation to spinal cord synaptosomes, increasing MEK-ERK phosphorylation.
  • BRAF physically interacted with NMDARs in both rat and human spinal cords.
  • BRAF inhibition (vemurafenib) or Braf deletion reversed morphine-induced NMDAR phosphorylation, trafficking, and hyperactivity.
  • Targeting BRAF or MEK, or deleting Braf, enhanced morphine analgesia and reduced hyperalgesia and tolerance.

Conclusions:

  • BRAF overactivity at nociceptor central terminals is a key mediator of opioid-induced NMDAR hyperactivity.
  • BRAF kinase signaling is critical for the development of opioid-induced hyperalgesia and tolerance.
  • Clinically approved BRAF inhibitors may offer a strategy to enhance opioid efficacy and mitigate adverse effects.

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Nociception01:44

Nociception

Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain. Thus, pain helps the...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Somatosensation01:33

Somatosensation

The somatosensory system relays sensory information from the skin, mucous membranes, limbs, and joints. Somatosensation is more familiarly known as the sense of touch. A typical somatosensory pathway includes three types of long neurons: primary, secondary, and tertiary. Primary neurons have cell bodies located near the spinal cord in groups of neurons called dorsal root ganglia. The sensory neurons of ganglia innervate designated areas of skin called dermatomes.
Pain01:20

Pain

Pain serves as a critical warning signal that alerts the body to potential or actual harm. When mechanical pressure on the skin is intense, such as from a sharp pinch, the sensation transitions from touch to pain. Similarly, extreme temperatures, like a hot pot handle, convert the sensation of heat into pain. Pain can also result from overstimulation of other senses, such as blinding light, loud noise, or the intense heat from habañero peppers. This ability to sense pain is essential for...